Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.
Authors: Musunuru K,  Strong A,  Frank-Kamenetsky M,  Lee NE,  Ahfeldt T,  Sachs KV,  Li X,  Li H,  Kuperwasser N,  Ruda VM,  Pirruccello JP,  Muchmore B,  Prokunina-Olsson L,  Hall JL,  Schadt EE,  Morales CR,  Lund-Katz S,  Phillips MC,  Wong J,  Cantley W,  Racie T,  Ejebe KG,  Orho-Melander M,  Melander O,  Koteliansky V,  Fitzgerald K,  Krauss RM,  Cowan CA,  Kathiresan S,  Rader DJ
Journal: Nature
Date: 2010 Aug 5
Branches: LTG, BB
PubMed ID: 20686566
PMC ID: PMC3062476
Abstract: Recent genome-wide association studies (GWASs) have identified a locus on chromosome 1p13 strongly associated with both plasma low-density lipoprotein cholesterol (LDL-C) and myocardial infarction (MI) in humans. Here we show through a series of studies in human cohorts and human-derived hepatocytes that a common noncoding polymorphism at the 1p13 locus, rs12740374, creates a C/EBP (CCAAT/enhancer binding protein) transcription factor binding site and alters the hepatic expression of the SORT1 gene. With small interfering RNA (siRNA) knockdown and viral overexpression in mouse liver, we demonstrate that Sort1 alters plasma LDL-C and very low-density lipoprotein (VLDL) particle levels by modulating hepatic VLDL secretion. Thus, we provide functional evidence for a novel regulatory pathway for lipoprotein metabolism and suggest that modulation of this pathway may alter risk for MI in humans. We also demonstrate that common noncoding DNA variants identified by GWASs can directly contribute to clinical phenotypes.